Richard S. Rimer
Presidente presso OmniMetrix LLC
Provenienza dei contatti di primo grado di Richard S. Rimer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Acorn Factor, Inc.
 Acorn Factor, Inc. Electric UtilitiesUtilities Data Systems & Software operates in two primary business segments. Subsidiary DataBit resells computer hardware and software from a number of manufacturers. The company also provides software consulting and development services through its dsIT Technologies subsidiary in Israel. The company generates more than 50% of its sales by reselling computer hardware and software. Customers in the US account for about 60% of sales. The company owns a minority interest in Comverge, which provides products that energy utilities use to service and manage customers.
12
| Extinct | Electric Utilities | 12 |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland.
8
| Private Company | Investment Managers | 8 |
DSIT Solutions Ltd.
 DSIT Solutions Ltd. Aerospace & DefenseElectronic Technology DSIT Solutions Ltd. develops underwater security, sonar and acoustics systems. It offers underwater security, acoustic analysis, anti-submarine warfare systems, and sonar simulation solutions to the commercial, energy, defense, and homeland security markets. The company was founded in 1993 and is headquartered in Givat Shmuel, Israel
6
| Subsidiary | Aerospace & Defense | 6 |
OmniMetrix LLC
 OmniMetrix LLC Electric UtilitiesUtilities In 1998, OmniMetrix introduced the first wireless remote monitor for on-site power generation - a truly innovative product at that time. Since then, demand for wireless monitors has skyrocketed as consumers worldwide have begun to rely on the continuous stream of valuable information contained within their gensets. OmniMetrix has remained the leader in this industry by finding innovative ways to help customers meet their on-site power and standby power needs. OmniMetrix provides expert capabilities in the design and development of wireless field devices and internet-connected data management systems. This includes microprocessor-based, miniature, on-machine field equipment, fully redundant SQL-based data management, and web-delivered equipment status pages. While most OmniMetrix systems are used in electric power applications, they also build systems for Corrosion Prevention and Pipeline Monitoring.
5
| Subsidiary | Electric Utilities | 5 |
Top Quartile Partners SA
 Top Quartile Partners SA Financial ConglomeratesFinance Top Quartile Partners SA is an alternative investment manager. The private company is based in Geneva, Switzerland.
1
| Private Company | Financial Conglomerates | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Richard S. Rimer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMERICAN PACIFIC CORPORATION | Chemicals: Major Diversified | Director/Board Member | |
| NOVELSTEM INTERNATIONAL CORP. | Biotechnology | Chairman Director/Board Member | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member | |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
US Seismic Systems, Inc.
 US Seismic Systems, Inc. Electrical ProductsProducer Manufacturing US Seismic Systems, Inc. designs, manufactures, and distributes fiber optics systems. The company is headquartered in Chatsworth, CA. | Electrical Products | Director of Finance/CFO Director/Board Member Chairman Director/Board Member | |
Useed, Inc.
 Useed, Inc. Packaged SoftwareTechnology Services Useed, Inc. provides an online crowdfunding platform for higher education. It offers USEED, a platform that helps students, faculty, and educational staff to empower in executing a crowdfunding campaign. The firm’s products include Funderbolt, crowdfunding, giving day, and matchups. Its services include crowdfunding training and governance and digital fundraising consulting services. The company was founded by Tim Walsh, Brian Sowards and Matthew Racz in 2011 and is headquartered in Scottsdale, AZ. | Packaged Software | Chairman Director/Board Member | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| New York University | College/University | Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Baruch College | College/University | Undergraduate Degree Masters Business Admin | |
| Bar-Ilan University | College/University | Masters Business Admin Graduate Degree | |
EnerTech Capital Partners
 EnerTech Capital Partners Investment ManagersFinance EnerTech Capital Partners (EnerTech Capital) is a venture capital firm founded in 1996 by Scott Ungerer. The firm is headquartered in Ambler, Pennsylvania. | Investment Managers | Founder Private Equity Investor | |
| ACORN ENERGY, INC. | Electronic Equipment/Instruments | Chief Executive Officer Founder Director/Board Member General Counsel Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director of Finance/CFO Chief Executive Officer Chairman | |
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
LinguaFlex, Inc.
 LinguaFlex, Inc. Medical SpecialtiesHealth Technology LinguaFlex, Inc. develops, manufactures and distributes medical devices for the treatment of sleep apnea. It offers the LinguaFlex Tongue Retractor which is a minimally invasive device designed to be inserted into the tongue by a thin needle. The LinguaFlex Tongue Retractor is designed not to interfere with normal tongue functions such as speech and swallowing and to be removed or replaced in a doctor’s office in a short period of time without the need for anesthesia. The company was founded by Ira Sanders in 2007 and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
| Université Paris Nanterre | College/University | Doctorate Degree | |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder | |
Kymo Therapeutics Ltd.
 Kymo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kymo Therapeutics Ltd. develops and commercializes therapeutic products . The company was founded on May 23, 2016 and is headquartered in Hatfield, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member | |
Mavalon Therapeutics Ltd.
 Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Mavalon Therapeutics Ltd. develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients. The company is headquartered in Hatfield, the United Kingdom. | Medical Specialties | Director/Board Member | |
Kaerus Bioscience France SASU
 Kaerus Bioscience France SASU Miscellaneous Commercial ServicesCommercial Services Kaerus Bioscience France SASU engages in research and development in biotechnology. The company was founded on February 23, 2017 and is headquartered in Orléans, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Human Antibody Factory Ltd.
 Human Antibody Factory Ltd. BiotechnologyHealth Technology Human Antibody Factory Ltd. provides research and experimental development on biotechnology. The company was founded by David John Grainger and is headquartered in Hatfield, the United Kingdom. | Biotechnology | Director/Board Member | |
Yukin Therapeutics SAS
 Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
| Kaerus Bioscience Ltd. | Director/Board Member | ||
Villaris Therapeutics, Inc.
 Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Villaris Therapeutics, Inc. is an asset-centric biopharmaceutical company. The company is based in Cary, NC. The company was founded in 2019 by John Harris. The CEO is Andrea Epperly. | Pharmaceuticals: Major | Director/Board Member | |
| Pearl River Bio GmbH | Director/Board Member | ||
| Pega-One SAS | Director/Board Member | ||
| Medicxi Ventures (Jersey) Ltd. (Switzerland) | Corporate Officer/Principal | ||
| Nira Biosciences, Inc. | Director/Board Member | ||
| ALDENA THERAPEUTICS, INC. | Director/Board Member | ||
| Vimela Therapeutics Ltd. | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 25 |
| Francia | 9 |
| Regno Unito | 9 |
| Svizzera | 5 |
| Paesi Bassi | 3 |
Settori
| Health Technology | 22 |
| Consumer Services | 7 |
| Finance | 5 |
| Technology Services | 4 |
| Producer Manufacturing | 3 |
Posizioni
| Director/Board Member | 131 |
| Corporate Officer/Principal | 28 |
| President | 25 |
| Chairman | 23 |
| Independent Dir/Board Member | 15 |
Contatti più connessi
| Insiders | |
|---|---|
| Michèle Ollier | 40 |
| Laurie Yoler | 25 |
| John Moore | 25 |
| Scott Ungerer | 25 |
| Jan Loeb | 21 |
| Christopher Clouser | 19 |
| Tony Zappalá | 14 |
| Tracy Clifford | 13 |
| Christopher Barchak | 9 |
| Roman J. Fleck | 8 |
| Richard J. Giacco | 8 |
| Joseph Musanti | 8 |
| Samuel Zentman | 7 |
| Michael H. Barth | 6 |
| Andre Aubert | 5 |
- Borsa valori
- Insiders
- Richard S. Rimer
- Connessioni Società
